115 related articles for article (PubMed ID: 10937982)
21. The acute effect of perindopril upon effort capacity in congestive heart failure.
Zdrenghea D; Angheloiu O; Icusca G; Timiş D
Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
[TBL] [Abstract][Full Text] [Related]
22. Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome.
Eizenberg Y; Grossman E; Peleg E; Shabtai Z; Sharabi Y
J Am Soc Hypertens; 2014 Apr; 8(4):227-31. PubMed ID: 24560177
[TBL] [Abstract][Full Text] [Related]
23. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
24. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
25. [When does the treatment with captopril show a better improvement in physical performance in patients with heart failure?].
Canesin MF; Barretto AC; Oliveira Júnior MT; Bodanese LC; Marafon P; Arsencio SR
Arq Bras Cardiol; 1996 Aug; 67(2):77-80. PubMed ID: 9110437
[TBL] [Abstract][Full Text] [Related]
26. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
Chodjania Y; Tharaux PL; Ragueneau I; Dussaule JC; Picker JL; Funck-Brentano C; Jaillon P
Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
28. Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction.
Yoshida K; Yasujima M; Casley DJ; Johnston CI
Jpn Circ J; 1998 Sep; 62(9):680-6. PubMed ID: 9766707
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin converting enzyme inhibition in heart failure.
Cleland JG; Dargie HJ; Robertson JI
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):157S-160S. PubMed ID: 6099732
[TBL] [Abstract][Full Text] [Related]
30. Congestive heart failure in elderly patients: controlled study of delapril versus captopril.
Acanfora D; Lanzillo T; Papa A; Longobardi G; Furgi G; Rengo C; Melillo E; Rengo F
Am J Cardiol; 1995 Jun; 75(18):37F-43F. PubMed ID: 7778533
[TBL] [Abstract][Full Text] [Related]
31. Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study.
Dorszewski A; Göhmann E; Dorsźewski B; Werner GS; Kreuzer H; Figulla HR
J Card Fail; 1997 Jun; 3(2):91-6. PubMed ID: 9220308
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the safety and efficacy of delapril with captopril in outpatients with congestive heart failure.
Fuchs W
Am J Cardiol; 1995 Jun; 75(18):29F-36F. PubMed ID: 7778531
[TBL] [Abstract][Full Text] [Related]
33. [The antianginal activity of angiotensin-converting enzyme inhibitors].
Cherevatov BG; Shelest AN
Lik Sprava; 1997; (5):50-3. PubMed ID: 9491696
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography.
Yoshida K; Kanazawa M; Casley DJ; Katopothis A; Johnston CI
J Cardiovasc Pharmacol; 1998 Nov; 32(5):702-8. PubMed ID: 9821842
[TBL] [Abstract][Full Text] [Related]
36. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
[TBL] [Abstract][Full Text] [Related]
37. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Kitaoka H; Takata J; Hitomi N; Furuno T; Seo H; Chikamori T; Doi YL
Am J Cardiol; 2000 Mar; 85(5):658-60, A10. PubMed ID: 11078286
[TBL] [Abstract][Full Text] [Related]
38. Failure of an ACE inhibitor to improve exercise tolerance. A randomized study of trandolapril. Trandolapril study group.
Hampton JR; Cowley AJ; Wnuk-Wojnar AM
Eur Heart J; 1998 Dec; 19(12):1823-8. PubMed ID: 9886725
[TBL] [Abstract][Full Text] [Related]
39. [The new class of drugs-- metalloprotease inhibitors -- in the treatment of heart failure].
Berezin AE
Klin Med (Mosk); 2004; 82(5):7-15. PubMed ID: 15230033
[No Abstract] [Full Text] [Related]
40. [The effect of captopril on the immediate quality of life in patients with congestive heart failure].
Han Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):154-6. PubMed ID: 1289024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
